NAII - ナチュラル・オルタ―ナティブス・インタ―ナショナル （Natural Alternatives International Inc.） ナチュラル・オルタ―ナティブス・インタ―ナショナルNAIIのチャート
NAIIの企業情報
| symbol | NAII |
|---|---|
| 会社名 | Natural Alternatives International Inc. （ナチュラル・オルタ―ナティブス・インタ―ナショナル） |
| 分野（sector） | Consumer Durables 耐久消費財 |
| 産業（industry） | Specialty Chemicals |
| 業種 | 医薬品 一般消費財（Consumer Products） |
| 概要 | 事業概要 ナチュラル・オルタナティブズ・インターナショナル（Natural Alternatives International Inc）は栄養補助食品の配合・製造・販売に従事する。同社は米国内外の消費者向けにビタミン、ミネラル、ハーブ及びその他の栄養補助食品、並びに他のヘルスケア製品の販売・流通を行う企業に対して、プライベートラベル製造受託サービスを提供する。また、同社は「Pathway to Healing」の製品ラインの下で、自社ブランド製品を開発・製造・販売する。同社は多様な消費者の好みに対応して、カプセル剤、錠剤、チュアブルウエハーと粉を含むさまざまな形の製品を製造する。同社の完全子会社であるNatural Alternatives International Europe S.A. (NAIE)はスイスのマンノに位置する製造・倉庫・包装・流通施設を運営している。 ナチュラル・オルタ―ナティブス・インタ―ナショナルは、米国の栄養補助食品メ―カ―。ビタミン、ミネラル、ハ―ブ、ヘルスケア製品を提供し、科学研究、臨床研究、顧客固有の処方、製品テストと評価、マ―ケティング管理とサポ―ト、包装・配送システム設計を含む栄養製品・サ―ビスを提供する。 Natural Alternatives International Inc. (NAI), headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. Its comprehensive partnership approach offers a wide range of innovative nutritional products and services to its clients including scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. |
| 本社所在地 | 1535 Faraday Drive Carlsbad CA 92008 USA |
| 代表者氏名 | Mark A. LeDoux マーク・A・ルドゥ |
| 代表者役職名 | Chairman of the Board of Directors Chief Executive Officer |
| 電話番号 | +1 619-744-7340 |
| 設立年月日 | 1980年 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 266人 |
| url | www.nai-online.com |
| nasdaq_url | https://www.nasdaq.com/symbol/naii |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 12.44100 |
| 終値（lastsale） | 9.45 |
| 時価総額（marketcap） | 71474215.05 |
| 時価総額 | 時価総額（百万ドル） 71.17168 |
| 売上高 | 売上高（百万ドル） 132.43700 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 47.55868 |
| 当期純利益 | 当期純利益（百万ドル） 8.06300 |
| 決算概要 | 決算概要 BRIEF: For the fiscal year ended 30 June 2018 Natural Alternatives International Inc. revenues increased 9% to $132.4M. Net income before extraordinary items increased 11% to $8.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from selling decrease of 10% to $14.4M (expense) Interest Income increase from $459K to $1.1M (income). |
NAIIのテクニカル分析
NAIIのニュース
Natural Alternatives International, Inc. Announces a $1 Million Increase in its Stock Repurchase Plan 2022/12/05 21:15:00 PR Newswire
CARLSBAD, Calif., Dec. 5, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced its Board of Directors authorized a $1.0 million increase to its stock…
Natural Alternatives International, Inc. Announces 2022 Q3 and YTD Results 2022/05/13 13:15:00 PR Newswire
2022 Q3: Net Income Increased 30.7% and Diluted EPS Increased 36.7% Q4 Fiscal 2022 Outlook: 18% - 21% Net Sales Increase CARLSBAD, Calif., May 13, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of…
Natural Alternatives International, Inc. Announces a $1 Million Increase in its Stock Repurchase Plan 2022/12/05 21:15:00 PR Newswire
CARLSBAD, Calif., Dec. 5, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced its Board of Directors authorized a $1.0 million increase to its stock…
Natural Alternatives International, Inc. Announces 2022 Q3 and YTD Results 2022/05/13 13:15:00 PR Newswire
2022 Q3: Net Income Increased 30.7% and Diluted EPS Increased 36.7% Q4 Fiscal 2022 Outlook: 18% - 21% Net Sales Increase CARLSBAD, Calif., May 13, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of…
Natural Alternatives International increases stock repurchase plan by $3M 2022/01/18 14:40:16 Seeking Alpha
Natural Alternatives International <> authorizes a $3M increase to its stock repurchase plan bringing the total plan authorized repurchase amount to $18M
Natural alternatives (NAI) announces a $3 million increase in its stock repurchase plan 2022/01/18 14:38:10 Seeking Alpha
Natural Alternatives International (NAI) adds $3M to its stock repurchase plan bringing the total plan authorized repurchase amount to $18M.The Company has purchased 1.9M shares
Natural Alternatives International (NASDAQ:NAII) Share Price Passes Below Two Hundred Day Moving Average of $14.86 2021/12/23 08:30:45 Dakota Financial News
Natural Alternatives International, Inc. (NASDAQ:NAII)s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $14.86 and traded as low as $12.37. Natural Alternatives International shares last traded at $12.50, with a volume of 22,562 shares changing hands. The firm has a market cap []
Critical Comparison: Natural Alternatives International (NAII) & Its Rivals 2021/12/05 08:46:42 ETF Daily News
Natural Alternatives International (NASDAQ: NAII) is one of 43 public companies in the Medicinals & botanicals industry, but how does it weigh in compared to its competitors? We will compare Natural Alternatives International to similar businesses based on the strength of its earnings, risk, valuation, institutional ownership, profitability, analyst recommendations and dividends. Risk and Volatility [] The post Critical Comparison: Natural Alternatives International (NAII) & Its Rivals appeared first on ETF Daily News .
Contrasting Bon Natural Life (NYSE:BON) & Natural Alternatives International (NASDAQ:NAII) 2021/12/01 07:36:43 Transcript Daily
Bon Natural Life (NYSE:BON) and Natural Alternatives International (NASDAQ:NAII) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk. Analyst Ratings This is a summary of current recommendations and price targets []